Clinical TrialsSearch results
Number of results: 737
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- MCA Embolism Local Fibrinolytic Intervention Trial
- Middle cerebral artery embolism
- MELT Study Group
- 2005-09-08
Other
- phase II study of gefitinib as a first-line therapy in elderly patients with lung adenocarcinoma.
- lung adenocarcinoma
- West Japan Oncology Group
- 2005-09-08
Other
- Randomized phase II study of best available 5-FU versus low-dose Paclitaxiel in gastric cancer with peritoneal metastasis refractory to 5-FU containing regimen(JCOG0407)
- gastric neoplasm
- Japan Clinical Oncology Group(JCOG)
- 2005-09-08
Other
- A Phase I/II Study of Amrubicine and Irinotecan in Patients with Advanced Small Cell Lung Cancer
- small cell lung cancer
- West Japan Oncology Group
- 2005-09-09
Other
- A phase I/II study of concurrent chemoradiotherapy with irinotecan for advanced or recurrent uterine cancer
- uterine cancer (squamous cell carcinoma, adeno- and/or adenosquamous cell carcinoma, endometrial carcinoma, carcinosarcoma)
- National Hospital Organization Kobe Medical Center
- 2005-09-09
Other
- A phase I/II study of weekly intraperitoneal paclitaxel +monthly intravenous carboplatin for mullerian carcinoma (ovarian, tubal, and peritoneal carcinoma)
- Gynecological Mullerian tumors, such as ovarian, tubal, and peritoneal cancers.
- Natinonal Hospital Organization Kobe Medical Center
- 2005-09-09
Other
- A Randomized phase II study of docetaxel versus weekly carboplatin and CPT-11 for previously treated Non-Small cell lung cancer
- second line chemotherapy for Non-Small cell lung cancer
- West Japan Oncology Group
- 2005-09-09
Other
- Dose-intensive weekly combination chemotherapy (cisplatin, vincristine, doxorubicin and etoposide) followed by cisplatin-etoposide therapy with concurrent thoracic irradiation: evaluation of a new treatment for limited-disease small-cell lung cancer.
- limited-disease small-cell lung cancer
- West Japan Oncology Group
- 2005-09-09
Other
- Hypertension Objective Treatment Based on Measurement by Electrical Devices of Blood Pressure (HOMED-BP) Study: Prospective Randomized Open-label Blinded Endpoint (PROBE)
- Untreated essential hypertensive patients
- HOMED-BP Study Group
- 2005-09-09
Other
- Phase II study of gefitinib in patients with EGFR mutation positive- advanced non-small cell lung cancer
- non-small cell lung cancer
- West Japan Oncology Group
- 2005-09-09